English | 简体中文 | 繁體中文 | 한국어 | 日本語
Tuesday, 28 July 2020, 11:00 HKT/SGT
Share:
    

Source: Theragen Bio Co Ltd
Theragen Bio analyzes Korea's largest COVID-19 patient and coronavirus genomic data

SEOUL, S.KOREA, July 28, 2020 - (ACN Newswire) - Theragen Bio is conducting joint research on developing a new coronavirus (COVID-19) genomic big data in collaboration with the Korea Research Institute of Chemical Technology (KRICT), Kyungpook National University Hospital, and the Daegu Metropolitan Government.


The study will analyze the full genome of each patient and the SARS-CoV-2 virus using samples from approximately 1,000 COVID-19 patients in Daegu and Gyeongsangbuk-do provence, the largest coronavirus genomic analysis to be conducted in Korea.

Through this study, Theragen hopes to identify the infection correlation between patient genome and the SARS-CoV-2 virus genome, and apply it to future vaccine development. Theragen identified the genetic correlation while establishing big data for SARS-CoV-2 mutations.

Based on its own Next Generation Sequencing (NGS), Theragen's ultra-sensitive Covid-19 RNA analysis system can decode over 30,000 full-legnth RNA sequences per virus. The SARS-CoV-2 virus mutates frequently, however the system can check RNA mutation, replication, and generation.

In addition, the evolution of the SARS-CoV-2 virus can be traced back to understand the transmission mechanisms between humans and predict clinical patterns, identify high-risk groups, improve the efficiency of PCR-based diagnosis, and secure evidence for prevention and prevention strategies.

Hwang Tae-soon, the CEO of Theragen Bio, explains, "This research is the first attempt to analyze whether there are differences in infection susceptibility depending on the genetic predisposition of infected patients as well as mutations and the evolution of the virus. It will be applicable to various infectious diseases in the future, as well as clinical prediction and vaccine development."

In April, Theragen Bio collaborated on research for a high-resolution genetic map of SARS-CoV-2, developed by Narry Kim, head of the RNA research group at the Institute for Basic Science (IBS), Hyeshik Chang, a professor at the Department of Biological Sciences, Seoul National University, in collaboration with Korea National Institute of Health (KNIH) within Korea Centers for Disease Control & Prevention (KCDC).

This study found the location of the coronavirus gene and RNA variations, to identify the transcriptome composition and the proliferation principles of the virus. In May, Theragen Bio traced the Seoul Itaewon cluster infections by sequencing the genomic materials and RNA transcriptomes and found that this SARS-CoV-2 variation originated in the U.S.

Theragen Bio, formerly the genome division of Theragen Etex (Kosdaq:066700), was spun off in March, 2020 to actively pursue customized pharmaceutical & new drug development and other projects featuring genomic technology. For further iniformation, please visit www.theragenbio.com.

Contact: Hyun Kim
Theragen Bio Co., Ltd.
Tel: +82-31-888-9313
Email: ngssales@theragenetex.com
Website: www.theragenbio.com


Topic: Press release summary
Source: Theragen Bio Co Ltd

Sectors: Healthcare & Pharm
https://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2026 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

 

Latest Press Releases
CaoCao Inc. Ushers in China's Fully Purpose-Built Robotaxi Era, Aims to Deploy 100,000 Robotaxis by 2030  
Monday, January 26, 2026 10:51:00 AM
FDA Accepts LEQEMBI(R) IQLIK(TM) (lecanemab-irmb) Supplemental Biologics License Application as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer's Disease under Priority Review  
Monday, January 26, 2026 10:37:00 AM
Fujitsu to support Mizuho Financial Group's human capital disclosure with a non-financial information collection and disclosure support service  
Monday, January 26, 2026 9:45:00 AM
Masar Destination Achieves LEED for Communities Gold Certification  
Jan 24, 2026 08:00 HKT/SGT
Sir Ivan Releases "Love Is The Piece"  
Jan 24, 2026 07:00 HKT/SGT
Open World Launches Saudi Arabia's First RWA Tokenization Center of Excellence to Advance Vision 2030 Digital Economy Goals  
Jan 23, 2026 23:00 HKT/SGT
TOYOTA GAZOO Racing Announces GR Yaris Sebastien Ogier 9x World Champion Edition  
Friday, January 23, 2026 6:26:00 PM
NEC Develops New 5G Base Station Radio Unit for Enhanced Communication Throughput, Compactness, and Energy Efficiency  
Friday, January 23, 2026 2:00:00 PM
GlobalLogic and Elektrobit Strengthen Partnership to Accelerate Next-Generation Software-Defined Vehicles  
Friday, January 23, 2026 1:12:00 PM
HKTDC and Microsoft Hong Kong jointly launch the Microsoft AI Adoption Programme Helping SMEs boost productivity through AI and accelerate digital transformation  
Jan 23, 2026 11:54 HKT/SGT
More Press release >>
 Events:
More events >>
Copyright © 2026 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575